Synairgen plc (LON:SNG – Get Rating) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 19.75 ($0.24) and traded as low as GBX 12.50 ($0.15). Synairgen shares last traded at GBX 13.85 ($0.17), with a volume of 1,251,966 shares traded.
Synairgen Stock Performance
The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.35. The stock has a market cap of £27.89 million and a PE ratio of -0.57. The company's 50 day simple moving average is GBX 15.51 and its 200 day simple moving average is GBX 19.75.
Synairgen Company Profile
(Get Rating)
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
Read More
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.